Back to
Wells Fargo & Company
AXSM
Showing 8 of 28 quarters
Position history for
Wells Fargo & Company's holdings in Axsome Therapeutics, Inc.
Yes. Wells Fargo holds 53,915 shares of AXSM (Axsome Therapeutics), worth $13.2M, as of its Q2 2026 13F filing. It reduced the position by 7,490 shares (-12.2%) from Q1 2026. Wells Fargo has held AXSM in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$13.2M
Current Shares
53,915
Total Value Change
+$9.6M
Total Shares Change
+13,958
Quarter-by-Quarter History